chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: 101.5F temp over night; significant pain in the injected arm; muscle aches; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number not reported), via an unspecified route of administration, administered in Arm Left on 06Mar2021 08:00 (age at vaccination 57-year-old) as 2nd dose, single for COVID-19 immunisation. Facility type for vaccination was other. The patient took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunisation. Medical history included known allergies to Ivp dye, chronic sinusitis, high cholesterol. The patient did not have COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not tested for Covid post vaccination. Concomitant medications in two weeks included rosuvastatin (ROSUVASTATIN), ezetimibe (ZETIA) and Thorne multivitamin. On 06Mar2021 21:00, the patient experienced 101.5 f temperature overnight, significant pain in the injected arm, muscle aches, headache. The patient underwent lab tests and procedures which included body temperature: 101.5 Fahrenheit on 06Mar2021 101.5F temp overnight. The patient did not receive any treatment. The outcome of events was not recovered.   No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Hiccups
Clinical narrative: Hiccups; This is a spontaneous report from a contactable other health care professional (patient himself). A 49-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: En6205), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 at 15:00 (at the age of 49-year-old) as SINGLE DOSE for covid-19 immunization. Medical history included Htn, sleep apnoea and low testosterone. The patient had no known allergies. Concomitant medication(s) included gabapentin (GABAPENTIN); lisinopril (LISINOPRIL); sildenafil (VIAGRA [SILDENAFIL]); anastrozole (ARIMIDEX) and testosterone (TESTOSTERONE). The patient had no other vaccine in four weeks. The patient not had covid prior vaccination. On 05Mar2021 at 17:15, the patient experienced Hiccups began shortly after injection and have now continued for 36hrs. The patient had not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of the event was not recovered.    No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, SARS-CoV-2 antibody test, Tachycardia
Clinical narrative: Heart rate went up to 182 resting rate reported 12 hours after vaccine , was taken to hospital for monitoring .; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 33-year-old non-pregnant female patient received bnt162b2 second dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6203), via an unspecified route of administration, administered in arm left on 05Mar2021 10:00 (at the age of 33-year-old) as 2nd dose, single dose for covid-19 immunization. The patient's medical history included known allergies to Penicillin. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9266) on 12Feb2021 at 08:00 as a single dose in left arm for COVID-19 immunization. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient didn't receive other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced heart rate went up to 182 resting rate reported 12 hours after vaccine, was taken to hospital for monitoring on 05Mar2021 22:00. The patient visited emergency room and was treated with IV (intravenous) medication (unspecified) for the event. The patient underwent lab tests and procedures which included sars-cov-2 antibody test (nasal swab) was negative and heart rate went up to 182 on 05Mar2021. The outcome of the event was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Cold sweat, Erythema, Fatigue
Clinical narrative: Pain and swelling at injection site; Pain and swelling at injection site; Chills; extreme tiredness; cold sweats; back pain; rash covering my body; red with almost hive like bumps; red with almost hive like bumps; This is a spontaneous report from a contactable other HCP. A 25-years-old female patient (not pregnant at the time of vaccination) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6206, via unspecified route, in left arm on 05Mar2021 12:30 PM (at 25-years age) as 2 nd dose, single dose for covid-19 immunization. The patient medical history included hypothyroidism and ADD (Attention deficit hyperactivity disorder), Known allergies to Ibuprofen and aspirin. The concomitant drug included Adderall and levothyroxine which was taken within two weeks. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EM9809, via unspecified route, in left arm on 11Feb2021 12:30 PM (at 25-years age) as 1 st dose, single dose for covid-19 immunization. The patient had no reaction for the first 12 hours.  On 06Mar2021, pain and swelling at injection site started at about 12-hour post injection. Chills, extreme tiredness and cold sweats following that. Tiredness and back pain the following 24-36 hours. At 36 hours post injection she woke up to more cold sweats, back pain and then a rash covered her body. It was painless and no itchy. It was however red with almost hive like bumps on 06Mar2021 at 12:00 AM. The facility type vaccine was reported as other. No other vaccines in four weeks. The patient underwent lab tests and procedures which included COVID Test (SARS-CoV-2 test): result Negative (Nasal swab) on 03Mar2021. No covid prior to vaccination. The patient had received the treatment included Benadryl and Tylenol. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected. received the treatment included Benadryl and Tylenol. The outcome of the events was not recovered.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test, Urticaria, Vaccination site pain, Vaccination site swelling
Clinical narrative: Pain and swelling at injection site; Pain and swelling at injection site; Chills; extreme tiredness; cold sweats; back pain; rash covering my body; red with almost hive like bumps; red with almost hive like bumps; This is a spontaneous report from a contactable other HCP. A 25-years-old female patient (not pregnant at the time of vaccination) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6206, via unspecified route, in left arm on 05Mar2021 12:30 PM (at 25-years age) as 2 nd dose, single dose for covid-19 immunization. The patient medical history included hypothyroidism and ADD (Attention deficit hyperactivity disorder), Known allergies to Ibuprofen and aspirin. The concomitant drug included Adderall and levothyroxine which was taken within two weeks. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EM9809, via unspecified route, in left arm on 11Feb2021 12:30 PM (at 25-years age) as 1 st dose, single dose for covid-19 immunization. The patient had no reaction for the first 12 hours.  On 06Mar2021, pain and swelling at injection site started at about 12-hour post injection. Chills, extreme tiredness and cold sweats following that. Tiredness and back pain the following 24-36 hours. At 36 hours post injection she woke up to more cold sweats, back pain and then a rash covered her body. It was painless and no itchy. It was however red with almost hive like bumps on 06Mar2021 at 12:00 AM. The facility type vaccine was reported as other. No other vaccines in four weeks. The patient underwent lab tests and procedures which included COVID Test (SARS-CoV-2 test): result Negative (Nasal swab) on 03Mar2021. No covid prior to vaccination. The patient had received the treatment included Benadryl and Tylenol. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected. received the treatment included Benadryl and Tylenol. The outcome of the events was not recovered.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Myalgia, Restlessness
Clinical narrative: prolific cold sweats; Muscle pain; restlessness; severe chills; This is a spontaneous report from a contactable Consumer. A 48-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EP6955) via an unspecified route of administration, administered in left arm on 06Mar2021 at 12.45 PM (at the age of 48-year-old) as single dose for COVID-19 immunization. The did not have allergies to medications, food, or other products. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to and since vaccination, the patient was not diagnosed with COVID-19. On 07Mar2021 (next day of vaccination) It was in the middle of the night (probably after midnight), the patient experienced muscle pain, restlessness, severe chills, prolific cold sweats. Did not received treatment for the adverse event. The outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Upper respiratory tract infection
Clinical narrative: upper respiratory tract sickness; This is a spontaneous report from a contactable consumer. This female consumer reported that she received first dose of BNT162b2 (Solution for injection, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: not reported) dose 1 via an unspecified route of administration on 19Feb2021 as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medication was not reported. On unspecified date she coincidentally has an upper respiratory tract sickness and has been sick for the past 8 days. She will be taking the second dose of the vaccine soon and she was uncomfortable in getting the second dose while sick. She wanted to postpone her appointment to 19Feb2021. The clinical outcome of the event was unknown.  No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth injury
Clinical narrative: deep lines around bottom of mouth; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non pregnant female patient received first dose of received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: en6205) via an unknown route of administration in right arm on 04Mar2021 at 17:30 (at the age of 65years) as 1st dose, single for COVID-19 immunisation. The patient medical history included allergies to penicillin and high blood pressure. Patient concomitant medications include ramipril and amlodipine taken in 2 weeks of vaccination. Patient received no other vaccine in four weeks. Patient had no covid prior vaccination and not tested for covid post vaccination. On 05Mar2021, the patient experienced deep lines around bottom of mouth. No treatment was received for the event. The outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Pain in extremity
Clinical narrative: Arm pain; fatigue; diarrhea; This is a spontaneous report from a contactable consumer (patient, self-reported). A 53-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9766 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 25Feb2021 at 01:15 PM, as a single dose for COVID-19 immunization at hospital. The patient did not receive any other vaccine in four weeks. The patient's medical history included HIV, rheumatoid arthritis, asthma, and adrenal insufficiency. The patient did not have any known allergies. Concomitant medications were not reported. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 26Feb2021, he experienced arm pain, fatigue, and diarrhea. The patient did not receive any treatment for the events. Outcome of the events was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Lymphadenopathy, Pain, Vaccination site pain, Vaccination site swelling
Clinical narrative: painful swelling of one or more lymph nodes; tennis ball sized knot in the arm; achy; pain and slight swelling at the injection site; pain and slight swelling at the injection site; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old adult non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,Lot Number: EN6203 and Expiry date: Unknown), dose 2 via an unspecified route of administration, on 05Mar2021 at 10:45  as 2ND DOSE, SINGLE for covid-19 administered in Arm Left immunization. Medical history included osteoarthritis, fibromyalgia, asthma and allergy to several foods. The patient did not receive any other vaccine in 4 weeks. Patient was not covid positive prior vaccination. The patient previously took celebrex and experienced Celebrex. Historical vaccination included the patient received dose 1 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiry date: Unknown), on 06Feb2021 at 10:45 am for COVID-19 immunization . On 05Mar2021 at 18:00, the patient experienced pain and slight swelling at the injection site, tennis ball sized knot in the arm and achy on 06Mar2021 and painful swelling of one or more lymph nodes on 07Mar2021. It was reported that on evening of injection (Friday) the patient had pain and slight swelling at the injection site. The next day (Saturday), she had a tennis ball sized knot in the arm which was slightly achy but not really painful. When she woke up on the second after the vaccine (Sunday) she noticed a somewhat painful swelling of one or more lymph nodes under her left arm extending slightly into her left breast. A hot shower has alleviated some of the swelling and pain so far. she expected this would ease up in the next few days. If it does not, she would seek medical advice. No treatment was given for the events. Patient was not tested for covid post vaccination. Outcome of the events were resolving.   No follow-up attempts are possible. No further information is expected
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Sore arm at injection site; body aches/pain; This is a spontaneous report from a contactable consumer. A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6199), dose 1 via an unspecified route of administration, administered in right Arm on 06Mar2021 at 16:30 (at the age of 53 years old) as 1STDOSE, SINGLE for covid-19 immunisation. Medical history included high blood pressure, diabetes and covid. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any known allergies. The patient did not receive any other vaccines within four weeks of the vaccination. Concomitant medications included metformin (METFORMIN, bisoprolol (BISOPROLOL), citalopram (CITALOPRAM), lisinopril (LISINOPRIL) and prilocaine hydrochloride (PRILOC) taken for an unspecified indication, start and stop date were not reported taken as other medications in two weeks. On 07Mar2021, the patient experienced sore arm at injection site, body aches and pain. The patient not received treatment for events. Post vaccination, the patient not been tested for covid. Outcome of the events was Unknown.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at injection site.; This is a spontaneous report was received from a non-contactable consumer (Patient). A 72-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6202 and expiry date was not reported), via an unspecified route of administration, administered in arm left on 06Mar2021 09:45, as 1st dose, single dose for covid-19 immunisation. The patient's medical history included type 2 diabetes mellitus. The patient's concomitant medications were not reported. The patient had no known allergies. Patient did not receive any other vaccines in 4 weeks. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. On an unspecified date in 2021, the patient experienced sore arm at injection site. On an unspecified date in 2021, the patient was recovered from the event.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Daily pain due to arthritis in legs and feet. I felt very relaxed after my 1st covid shot; This is a spontaneous report from a contactable consumer (Patient). A 66-years-old non-pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6198, age at vaccination 66 years), dose 1 via an unspecified route of administration, administered in left arm on 26Feb2021 at 10:15 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included Cervical stenosis, allergies sulfa, pain, arthritis leg and feet ongoing. Concomitant medications included hydrochlorothiazide, triamterene (TRIAMTERENE HCTZ) taken for an unspecified indication, estradiol (VIVELLE DOT) taken for an unspecified indication. Facility type vaccine was pharmacy or drug store. No other vaccine in four weeks. The patient experienced; this was a fantastic event. Patients suffer from daily pain due to arthritis in legs and feet. Patient felt very relaxed after my 1st covid shot. In addition, felt absolutely no pain in body for 24 hrs. after shot. Wish isolated pain medicine in the vaccine. patient would take whatever med it was for the rest of her life. Patient had not covid prior vaccination. Patient was not been covid tested post vaccination. The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Cold sweat, Headache
Clinical narrative: soreness under her armpit; pain at the front and top of her head; cold sweats; chills; This is a spontaneous report from a contactable consumer (patient). A 51-years-old female consumer patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided), via an unspecified route of administration, on 04Mar2021 (at the age of 51-years-old) as a single dose for covid-19 immunisation. Patient's medical history and concomitant medications were not reported. On an unspecified date, as reported, patient was still experiencing soreness under her armpit where she had the injection, pain at the front and top of her head, cold sweats and chills. The reporter asked was this common and when should she be concern. The reporter asked a question that can she take Tylenol after receiving the Pfizer Covid-19 vaccine. The outcome for the events were not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis psoriasiform, Dry skin, Erythema, Metamyelocyte count, Metamyelocyte count increased
Clinical narrative: Rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where their is hair.; Rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where their is hair.; Rough skin and you could feel lampiness under the rash; skin is red and looks like increased melanocytes; skin is red and looks like increased melanocytes; This is a spontaneous report from a contactable physician (patient). A 64-years-old male patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number:  ELO140, Expiration date; unknown), via an intramuscular route of administration, in Arm Left on 31Dec2020 08:00 as Unknown, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not have covid prior to vaccination. On 08Jan2021, the patient experienced rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where there was hair. Rough skin and they could feel lumpiness under the rash. Hair got destroyed above skin used steroids. Improved. But still skin was red and looked like increased melanocytes. don't know if it was TH1 immune response. adverse event resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included metamyelocyte count: increased on skin is red and looks like increased melanocytes, sars-cov-2 antibody test: negative on 24Dec2020. Therapeutic measures were taken as a result of events. Patient was treated with high potency steroid creams for the events. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 antibody test
Clinical narrative: Rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where their is hair.; Rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where their is hair.; Rough skin and you could feel lampiness under the rash; skin is red and looks like increased melanocytes; skin is red and looks like increased melanocytes; This is a spontaneous report from a contactable physician (patient). A 64-years-old male patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number:  ELO140, Expiration date; unknown), via an intramuscular route of administration, in Arm Left on 31Dec2020 08:00 as Unknown, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not have covid prior to vaccination. On 08Jan2021, the patient experienced rash on few fingers look like psoriatic but it selected not the knuckles but between dip and pip joints where there was hair. Rough skin and they could feel lumpiness under the rash. Hair got destroyed above skin used steroids. Improved. But still skin was red and looked like increased melanocytes. don't know if it was TH1 immune response. adverse event resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included metamyelocyte count: increased on skin is red and looks like increased melanocytes, sars-cov-2 antibody test: negative on 24Dec2020. Therapeutic measures were taken as a result of events. Patient was treated with high potency steroid creams for the events. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on both forearms.; This is a spontaneous report from a contactable consumer (patient himself). A 70-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number was not reported) via an unspecified route of administration in left arm on 03Mar2021 at 15:00 as 2nd dose single dose for COVID-19 immunization. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6202 Expiry date: unknown) via an unspecified route of administration on 10Feb2021 at 09:00 for COVID-19 immunization. The patient's medical history included pulmonary resection. The patient had not received any other vaccines within 4 weeks. The patient was not diagnosed prior and since the vaccination with COVID-19. The patient's concomitant medications was not reported. The patient experienced rash on both forearms on 05Mar2021 at 13:00. The patient had not received treatment for the adverse events. The outcome of event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Hypoaesthesia, Hypoaesthesia oral, Pain in extremity, Pharyngeal hypoaesthesia
Clinical narrative: Arm sore; rash on chest; tight chest; numbness and swelling on left side of face; numbness and swelling on left side of face; numbness and swelling on left side of face, throat; numbness and swelling on left side of face, throat; numbness and swelling on left side of face, throat, and tongue.; numbness and swelling on left side of face, throat, and tongue; This is a spontaneous report received from a contactable other health care professional (Patient herself). A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration (at the age of vaccination 33-year) in Left Arm on 07Mar2021 10:30 as 1st dose, single for COVID-19 immunization. Medical history included asthma, Known allergies, endometriosis, anxiety and depression. Concomitant medications included fluoxetine hydrochloride (PROZAC); clonazepam (KLONOPIN); albuterol (SALBUTAMOL); elagolix sodium (ORILISSA) and lamotrigine (LAMICTAL). The patient haven't tested COVID prior and post vaccination. On 07Mar2021 10:30 the patient experienced arm sore, rash on chest, tight chest, numbness and swelling on left side of face, throat, and tongue. Therapeutic measures were taken as a result of the events. The patient visited Emergency room for the events. Patient was treated with Epi-pen, benadryl, albuterol, prednisone. The seriousness of the events was reported as non-serious. The clinical outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Rash, Swelling face, Swollen tongue
Clinical narrative: Arm sore; rash on chest; tight chest; numbness and swelling on left side of face; numbness and swelling on left side of face; numbness and swelling on left side of face, throat; numbness and swelling on left side of face, throat; numbness and swelling on left side of face, throat, and tongue.; numbness and swelling on left side of face, throat, and tongue; This is a spontaneous report received from a contactable other health care professional (Patient herself). A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration (at the age of vaccination 33-year) in Left Arm on 07Mar2021 10:30 as 1st dose, single for COVID-19 immunization. Medical history included asthma, Known allergies, endometriosis, anxiety and depression. Concomitant medications included fluoxetine hydrochloride (PROZAC); clonazepam (KLONOPIN); albuterol (SALBUTAMOL); elagolix sodium (ORILISSA) and lamotrigine (LAMICTAL). The patient haven't tested COVID prior and post vaccination. On 07Mar2021 10:30 the patient experienced arm sore, rash on chest, tight chest, numbness and swelling on left side of face, throat, and tongue. Therapeutic measures were taken as a result of the events. The patient visited Emergency room for the events. Patient was treated with Epi-pen, benadryl, albuterol, prednisone. The seriousness of the events was reported as non-serious. The clinical outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Paraesthesia
Clinical narrative: Developed paresthesia (tingling, pins and needles) in legs and arms, intermittent, moves around; more predominant in feet and hands; tender left supraclavicular lymphadenopathy (same side as vaccine administration); This is a spontaneous report from a contactable physician (patient). A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 11:30 (at the age of 50 years old) as 2nd dose, single for COVID-19 immunization. Medical history included paraesthesia (10 years ago) lasting approximately 8 weeks, diagnostic evaluation was negative, self-resolved (no history of vaccination then), hypercholesterolaemia from an unknown date and unknown if ongoing. No known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included atorvastatin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 10Feb2021 12:15 as 1st dose, single for COVID-19 immunization. 06Mar2021 13:00, the patient developed paraesthesia (tingling, pins, and needles) in legs and arms, intermittent, moves around and more predominant in feet and hands. The patient also had tender left supraclavicular lymphadenopathy same side as vaccine administration. The patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Minor headache; This is a spontaneous report from a contactable other health professional, the patient. A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 06Mar2021 10:30 (Batch/Lot Number: EN6205) (at the age of 32-year-old) as 1st dose, single dose for covid-19 immunisation. Medical history included none and no known allergies. Concomitant medication(s) included omega-3 fatty acids; amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) both taken for an unspecified indication, start and stop date were not reported and multivitamin (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021 17:15, the patient experienced minor headache. Therapeutic measures were taken as a result of event and included treatment with Advil at 2x 200mg. The outcome of the event was recovered on an unknown date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomited 5 times 7 hours after receiving the vaccine. No blood from vomiting.; This is a spontaneous report from a contactable consumer (patient herself). A 20-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6206), via an unspecified route of administration in right arm on 06Mar2021 at 16:30 (at the age of 20-year-old) as a single dose for COVID-19 immunization. The patient's medical history included known allergies: allergic to dust and pollen. Concomitant medications were not reported. The patient did not receive other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. On 06Mar2021 at 23:00, the patient experienced vomited 5 times 7 hours after receiving the vaccine. No blood from vomiting. The outcome of the event was recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash pruritic
Clinical narrative: a rash appeared on my half of my face from left chin to upper right forehead.; Rash is itchy and burns; Rash is itchy and burns; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non-pregnant adult female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205) via an unspecified route of administration, administered in Left arm on 04Mar2021 at 14:15 as First Dose, Single for COVID-19 immunization. The patient medical history not reported. There were no concomitant medications.The patient previously took pitocin [oxytocin] and experienced drug hypersensitivity. The patient did not take any other medications within two weeks of vaccination and no other vaccine within 4 weeks of vaccination. After about 4 hours of the vaccine administration On 04Mar2021,at 19:00,the patient reported a rash appeared on my half of my face from left chin to upper right forehead, rash is itchy and burns. Therapeutic measures were taken as a result of a rash appeared on my half of my face from left chin to upper right forehead, rash is itchy and burns. I have been applying Sarna cream and ice packs. The outcome for the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Headache, Paranasal sinus discomfort, Tinnitus
Clinical narrative: "sinus pressure" headache. Forehead, eyes. Ears ringing.; "sinus pressure" headache. Forehead, eyes. Ears ringing.; "sinus pressure" headache. Forehead, eyes. Ears ringing.; "sinus pressure" headache. Forehead, eyes. Ears ringing.; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in arm left on 19Feb2021 at 11:30 (at the age of 69-years-old) as 1st dose, single dose for COVID-19 immunisation. The patient medical history included hashimotos, glaucoma and had known allergies to penicilliin, Levaquin and Cipro. The patient did not received any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included Bimatoprost (LUMIGAN EYE DROP), Dorzolamide hydrochloride, timolol maleate (COSOPT EYE DROP), ciclosporin (RESTASIS) and Vit. On 19Feb2021 at 15:00, the patient experienced "sinus pressure" headache, forehead, eyes, ears ringing. The patient self-medicated with Motrin, Bufferin, Sudafed, Claritin and Tylenol. On 26Feb2021, the physician prescribed 6 day dose pack. The patient still had headache after 2 weeks. On 03Mar2021, she visited ear, nose and throat (ENT). The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of all the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Simple swelling and pain at the injection site; Simple swelling and pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 59-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Not available/provided to reporter at the time of report completion), via an unspecified route of administration, administered in left arm on 05Mar2021 12:30 as 1st dose, single for covid-19 immunisation. Facility type of vaccine was reported as other. The patient was not received other vaccine in four weeks. The patient was received unknown medications in two weeks. Medical history included Heart disease, asthma, hypertension, obesity and high col. The patient was allergic to Iodide based contrast, X-ray, dye and latex. Concomitant medications were not reported. The patient experienced simple swelling and pain at the injection site on 05Mar2021 01:00 PM. No other symptoms. The patient was not received treatment for adverse event. The was not tested prior and post vaccination. Outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Diarrhoea, Malaise, Pain
Clinical narrative: Diarrhea/loose stools; stomach cramps and pressure; stomach cramps and pressure; Overall achy feeling of being unwell; Overall achy feeling of being unwell; This is a spontaneous report from a contactable consumer. A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Left arm on 28Feb2021 11:30 (at the age of 67-years-old) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included Migraine headaches, hernia, GERD (gastroesophageal reflux disease), asthma, Known allergies to Z-Pac and Brazil nuts. Concomitant medications included omeprazole, cyanocobalamin (B12), topiramate, nortriptyline, citalopram, fish oil, rosuvastatin, magnesium, melatonin, curcuma longa (TURMERIC), polycarbophil calcium (FIBER), vitamin A [RETINOL], vitamin d3, calcium and multivitamins [vitamins nos] received in two weeks of vaccination. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 01Mar2021 at 06:00, the patient experienced, Diarrhea, stomach cramps and pressure for about 3 days. Then loose stools, cramps and pressure for 5 more days and overall achy feeling of being unwell. No treatment was received for adverse events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: 2 red small blotches on chest; This is an initial spontaneous report received from Pfizer Rx Pathways from a contactable consumer (patient). A male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number was not reported, Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 05Mar2021 12:30 as single dose for covid-19 immunisation. Medical history included diabetes mellitus, Allergy to Penicillin. Concomitant medications were not reported. On 07Mar2021, patient had 2 red small blotches on chest. No treatment received for the adverse event. the patient not receive any other vaccines within 4 weeks prior to the COVID vaccine; no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient not diagnosed with COVID-19; Since the vaccination, has the patient been not tested for COVID-19. The outcome for event was reported as not resolved. The outcome of the event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Rhinorrhoea
Clinical narrative: Runny nose; Stuffiness; Feels like she has "one heck of a cold; This is a spontaneous report from a contactable consumer (patient reported herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 06Mar2021, as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced runny nose and stuffiness on 07Mar2021. Also, she stated that she feels like she has one heck of a cold on 07Mar2021. she stated that she wanted to know if this is a possible side effect of vaccination, since she had only seen it listed as a covid symptom. The seriousness criteria of the events were reported as non-serious by the reporter. The outcome of the events was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at injection site; This is a spontaneous report from a contactable consumer (Patient) reported for herself. A 55-Year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration in left arm on 04Mar2021 at 09:15 (Lot number: EL3247), (at the age of 55-years-old) as first dose, single for COVID-19 immunization. The patient medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. No known allergies reported. Concomitant medications included ciclosporin (RESTASIS), estradiol, multivitamins, omega 3. The patient did not receive any vaccines within four weeks prior to the vaccination. On 04Mar2021, the patient experienced pain at injection site. The patient did not receive any treatment for the event. Outcome of the event was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinitis
Clinical narrative: Infection from the nose; This is a spontaneous report received from a contactable consumer (patient husband) via medical information team. A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter requested to reschedule the second dose of the patient which would be on 07Mar2021 as she was having the infection from the nose on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling
Clinical narrative: hurts; swollen; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age (Age 74 units unspecified) received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on 06Mar2021 18:00 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, after the vaccination the patient experienced side effects, it hurts likes a son of a gun and slightly swollen. The outcome of the events was reported as unknown at the time of report.  No follow-up attempts are possible. No information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in left arm; This is a spontaneous report from a contactable consumer (patient herself). A 42-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number and expiry date not reported) via an unspecified route of administration in Arm Left on 06Mar2021 at 13:30 as 1st dose, single dose for COVID-19 immunisation. The patient was pregnant. The patient's medical history was none. There were no known allergies. The patient's concomitant medication(s) included montelukast taken for an unspecified indication, azelastine taken for an unspecified indication, ethinylestradiol, norgestimate (ESTARYLLA) taken for an unspecified indication and Doterra Oils' taken for unspecified indication. No other vaccine in four weeks. No COVID prior vaccination and not tested COVID post vaccination. On 06Mar2021 at 19:00, the patient experienced soreness in left arm. Therapeutic measures were not taken as a result of adverse event. It was reported that lot was not reported as unable to locate or read the details. The outcome of the event was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Nausea, Oropharyngeal pain
Clinical narrative: headache; nausea; sore throat; cough; This is a spontaneous report from a contactable consumer (patient). A 57-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration at left arm on 02Mar2021 at 11:00 hours, as unknown, single dose (at the age of 57-years-old) for COVID-19 immunization. The patient medical history was not reported. Patient had no COVID-19 prior vaccination. Patient had not taken other vaccine in four weeks. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, route of administration, start and stop date were not reported. The patient previously took amoxicillin and experienced allergies. On 03Mar2021, patient experienced headache, nausea, sore throat and cough. Patient was not COVID-19 tested, post vaccination. Patient received no treatments for all the events. The outcome for all the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Fatigue; low grade fever (99.4); This is a spontaneous report from a contactable consumer(patient). A 68-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6204), via an unspecified route of administration in the left arm on 06Mar2021 at 09:30 as a single dose for COVID-19 Immunization. Historical vaccine included first dose of vaccine Pfizer BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number : EL9266) via an unspecified route of administration in the left arm on 13Feb2021 at 09:30 as a single dose (at the age of 68-years-old) for COVID-19 Immunization. The patient medical history included missing one kidney. Concomitant medication was Hydrochlorothiazide 25mg. Patient had no allergies. Patient did not receive vaccine in four weeks. On 07Mar2021, Patient experienced Fatigue and low grade fever (99.4). No treatment was given for the event. Patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.